Ligand Pharmaceuticals Inc. (LGND) Buys CyDex, Inc. For $31.2M Upfront In Cash
1/27/2011 6:36:02 AM
More...
|
CyDex, Inc. Announces New Corporate Name
11/20/2007 10:56:43 AM
More...
|
Pediatric Asthma Programs With CyDex, Inc. Captisol Technology Acquired by AstraZeneca PLC (AZN)
10/3/2007 8:52:08 AM
More...
|
Aradigm Corporation (ARDM) and CyDex, Inc. Sign Development Collaboration Agreement
9/6/2007 10:58:43 AM
More...
|
CyDex, Inc. Licenses Captisol(R) to Critical Therapeutics for Injectable Formulation of Zileuton
6/12/2007 2:12:35 PM
More...
|
CyDex, Inc. Licenses Captisol(R) to Sunesis Pharmaceuticals, Inc. (SNSS) for Oncology Drug Candidate
5/3/2007 12:20:17 PM
More...
|
CyDex, Inc. Licenses Captisol(R) to Proteolix, Inc. for Promising Oncology Compound
5/1/2007 12:23:23 PM
More...
|
CyDex, Inc. Announces Captisol Technology Used in Injection Formulation of Veterinary Anti-Emetic Cerenia(R) (Maropitant) Recently Approved for Marketing in Europe
4/10/2007 12:32:50 PM
More...
|
CyDex, Inc. Announces Captisol Technology Used In Recently Launched Injection Formulation Of Antipsychotic Medication ABILIFY(R) (aripiprazole)
12/18/2006 3:49:17 PM
More...
|
CyDex, Inc. Announces Captisol Technology Used In Recently Launched Injection Formulation Of Antipsychotic Medication ABILIFY(R) (aripiprazole)
12/14/2006 11:35:10 AM
More...
|
|